G.D. Johnson

6.1k total citations · 2 hit papers
84 papers, 5.0k citations indexed

About

G.D. Johnson is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, G.D. Johnson has authored 84 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in G.D. Johnson's work include Monoclonal and Polyclonal Antibodies Research (31 papers), Systemic Lupus Erythematosus Research (15 papers) and T-cell and B-cell Immunology (7 papers). G.D. Johnson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (31 papers), Systemic Lupus Erythematosus Research (15 papers) and T-cell and B-cell Immunology (7 papers). G.D. Johnson collaborates with scholars based in United Kingdom, Canada and United States. G.D. Johnson's co-authors include E. J. Holborow, G. I. Russell, R. Stephen Davidson, L. E. Glynn, Dean Goodwin, D. M. Weir, I. C. M. Maclennan, John Gordon, Jason Edmonds and N. R. Ling and has published in prestigious journals such as Nature, The Lancet and The Journal of Immunology.

In The Last Decade

G.D. Johnson

83 papers receiving 4.4k citations

Hit Papers

A simple method of reducing the fading of immunofluoresce... 1981 2026 1996 2011 1981 1982 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.D. Johnson United Kingdom 28 1.7k 988 759 662 581 84 5.0k
Su-Ming Hsu United States 33 1.5k 0.9× 1.2k 1.2× 454 0.6× 352 0.5× 282 0.5× 74 5.5k
Robert Auerbach United States 41 3.4k 2.0× 1.2k 1.2× 343 0.5× 476 0.7× 218 0.4× 124 6.8k
Paul H. Hardy United States 14 1.6k 0.9× 481 0.5× 320 0.4× 203 0.3× 983 1.7× 28 5.1k
Howard G. Meyer United States 7 1.5k 0.9× 390 0.4× 301 0.4× 189 0.3× 996 1.7× 15 4.7k
Patrik Maurer Germany 42 2.0k 1.2× 760 0.8× 556 0.7× 1.1k 1.7× 249 0.4× 60 4.7k
A F Purchio United States 48 5.1k 3.0× 784 0.8× 614 0.8× 437 0.7× 173 0.3× 85 8.4k
Leo T. Furcht United States 55 3.3k 1.9× 790 0.8× 699 0.9× 236 0.4× 1.1k 1.9× 134 8.4k
Roger L. Eddy United States 53 5.7k 3.4× 1.6k 1.6× 430 0.6× 384 0.6× 673 1.2× 129 9.9k
С. Kronheim South Africa 28 3.0k 1.8× 2.9k 2.9× 355 0.5× 211 0.3× 509 0.9× 50 6.8k
Ira M. Herman United States 47 3.7k 2.1× 509 0.5× 849 1.1× 328 0.5× 650 1.1× 112 8.9k

Countries citing papers authored by G.D. Johnson

Since Specialization
Citations

This map shows the geographic impact of G.D. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.D. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.D. Johnson more than expected).

Fields of papers citing papers by G.D. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.D. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.D. Johnson. The network helps show where G.D. Johnson may publish in the future.

Co-authorship network of co-authors of G.D. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of G.D. Johnson. A scholar is included among the top collaborators of G.D. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.D. Johnson. G.D. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ling, N. R., Debbie L. Hardie, G.D. Johnson, & I. C. M. Maclennan. (1998). Origin and properties of soluble CD21 (CR2) in human blood. Clinical & Experimental Immunology. 113(3). 360–366. 9 indexed citations
2.
Babad, H., et al.. (1992). The Hydrogen Program: The present understanding of cyclic venting tanks. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations
3.
Joplin, Ruth, Alastair J. Strain, James Neuberger, J. Gordon Lindsay, & G.D. Johnson. (1992). Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. The Lancet. 339(8785). 93–94. 79 indexed citations
4.
Johnson, G.D.. (1989). Methods in Cell Biology, Vol. 30: Fluorescence of Living Cells in Culture. Part B. Quantitative Fluorescence Microscopy—Imaging and Spectroscopy. Immunology. 68(3). 436. 15 indexed citations
5.
Gordon, John, Leopoldo Flores‐Romo, M J Millsum, et al.. (1989). CD23: a multi-functional receptor/ lymphokine?. Immunology Today. 10(5). 153–157. 182 indexed citations
6.
Ling, N. R., Deborah Hardie, J. Lowe, et al.. (1989). A phenotypic study of cells from burkitt lymphoma and ebv‐b‐lymphoblastoid lines and their relationship to cells in normal lymphoid tissues. International Journal of Cancer. 43(1). 112–118. 35 indexed citations
7.
Goddard, David H., et al.. (1984). Changes in normal polymorphonuclear leucocyte motility after ingestion of IgG aggregates.. Annals of the Rheumatic Diseases. 43(2). 146–150. 4 indexed citations
8.
Quakyi, Isabella A., et al.. (1979). Immunological abnormalities in caucasians with malaria. Immunology Letters. 1(3). 153–154. 14 indexed citations
9.
Johnson, G.D.. (1978). Fluorescent Antibody Techniques and their Applications: 2nd edn. Immunology. 35(3). 571. 5 indexed citations
10.
O’Donoghue, Diarmuid P., Michael Lancaster-Smith, G.D. Johnson, & Parveen Kumar. (1976). Gastric lesion in dermatitis herpetiformis.. Gut. 17(3). 185–188. 27 indexed citations
11.
Johnson, G.D.. (1970). Fluorescent Antibody Techniques and their Applications. Immunology. 19(2). 385. 95 indexed citations
12.
Farrow, L J, E. J. Holborow, G.D. Johnson, et al.. (1970). Autoantibodies and the Hepatitis-associated Antigen in Acute Infective Hepatitis. BMJ. 2(5711). 693–695. 107 indexed citations
13.
O’Neill, Philip D., G.D. Johnson, & C. S. Nicol. (1970). Evaluation of a modified FTA-ABS test multispot FTA-ABS.. Sexually Transmitted Infections. 46(4). 278–283. 4 indexed citations
14.
Beutner, E. H., E. J. Holborow, & G.D. Johnson. (1967). Quantitative studies of immunofluorescent staining. I. Analyses of mixed immunofluorescence.. PubMed. 12(3). 327–37. 57 indexed citations
15.
Johnson, G.D., E. J. Holborow, & L. E. Glynn. (1966). ANTIBODY TO LIVER IN LUPOID HEPATITIS. The Lancet. 288(7460). 416–418. 43 indexed citations
16.
Beutner, Ernst H., E. J. Holborow, & G.D. Johnson. (1965). A New Fluorescent Antibody Method: Mixed Antiglobulin Immunofluorescence or Labelled Antigen Indirect Immunofluorescence Staining. Nature. 208(5008). 353–355. 49 indexed citations
17.
Johnson, G.D. & E. J. Holborow. (1963). IMMUNOFLUORESCENT TEST FOR RHEUMATOID FACTOR IN SERUM. The Lancet. 282(7318). 1142–1143. 8 indexed citations
18.
Johnson, G.D., et al.. (1963). Demonstration by immunofluorescence of autoantibody in the serum of rabbits given injections of rat tissue. The Journal of Pathology and Bacteriology. 86(2). 521–525. 5 indexed citations
19.
Weir, D. M., E. J. Holborow, & G.D. Johnson. (1961). A Clinical Study of Serum Antinuclear Factor. BMJ. 1(5230). 933–937. 103 indexed citations
20.
Holborow, E. J., D. M. Weir, & G.D. Johnson. (1957). A Serum Factor in Lupus Erythematosus with Affinity for Tissue Nuclei. BMJ. 2(5047). 732–734. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026